Academic Journal
View in EDS

Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial

Bibliographic Details
Title: Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial
Authors: Paz-Ares, Luis, Goto, Yasushi, Wan-Teck Lim, Darren, Halmos, Balazs, Chul Cho, Byoung, Cobo, Manuel, Luis González Larriba, José, Zhou, Caicun, Demedts, Ingel, Atmaca, Akin, Baka, Sofia, Mookerjee, Bijoyesh, Portella, Socorro, Zhu, Zewen, Wu, Jincheng, Demanse, David, Dharan, Bharani, Reck, Martin
Source: In Lung Cancer March 2024 189
Database: ScienceDirect
More Details
ISSN:01695002
DOI:10.1016/j.lungcan.2023.107451
Published in:Lung Cancer
Language:English